Pharmadox Healthcare Ltd., TOWA Pharmaceuticals Europe, S.L.
PolandAll drugs from this manufacturer
-
In adults, it is used to prevent the formation of blood clots in the veins following hip or knee replacement surgery. In children, the medicine is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 86.48 mg ATC: B01AE07
-
The medicine is used in adults to prevent blood clots after hip or knee replacement surgery, to prevent strokes in people with atrial fibrillation, and to treat and prevent the recurrence of blood clots in the leg veins and lungs. In children, the medicine is used to treat blood clots and prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 126.83 mg ATC: B01AE07
-
This medicine is used in adults to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of blood clots in the veins of the legs and lungs. In children, it is used to treat blood clots and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage dabigatran etexilate 172.95 mg ATC: B01AE07